Cargando…
Effect of finasteride particle size reduction on its pharmacokinetic, tissue distribution and cellular permeation
Finasteride (FSD), a specific competitive inhibitor of the steroid type-II 5α-reductase enzyme, is used in treatment of benign prostate hyperplasia (BPH) and male pattern baldness. The drug is of limited solubility that affect its dissolution and bioavailability. The aim was to study the effect of F...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Taylor & Francis
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6058569/ https://www.ncbi.nlm.nih.gov/pubmed/29451038 http://dx.doi.org/10.1080/10717544.2018.1440446 |